Background The role of rituximab in combination with different CHOP (cyclophosphamide,
doxorubicin, vincristine, and prednisone)-like chemotherapy regimens in young patients with …

The combination of cyclophosphamide, vincristine, and prednisone (CVP) is one of several
standard treatment options for advanced follicular lymphoma. This, like similar …

Purpose To compare the long-term outcome of patients with previously untreated follicular
lymphoma (FL) needing therapy, after treatment with cyclophosphamide, vincristine and …

Background: In 2003, the Accreditation Council for Graduate Medical Education (ACGME)
mandated 80-hour resident duty limits. In 2011 the ACGME mandated 16-hour duty …

… Girouard C, Dufresne J, Imrie K, et al: Salvage chemotherapy with mini-BEAM for
relapsed or refractory non-Hodgkin’s lymphoma prior to autologous bone marrow …

Objective: To evaluate the effect of antileukemic chemotherapy administered at diagnosis
on the survival of patients with isolated chloroma. Design: Retrospective review of locally …

BACKGROUND Gemcitabine has been shown to have activity as a single agent in lymphoma
and, when combined with cisplatin, is effective therapy for a number of solid tumors. The …

Central nervous system ( CNS ) prophylaxis for diffuse large B ‐cell lymphoma ( DLBCL ) is
controversial with even less evidence in the era of R‐CHOP (rituximab, cyclophosphamide, …

A systematic review and meta-analysis was performed to determine the efficacy and toxicity
of thalidomide in previously untreated patients with myeloma. Medline, Embase, Cochrane …

PURPOSE To determine the frequency of return of ovarian function after autologous bone
marrow transplantation (ABMT), and the major factors that predict recovery. PATIENTS AND …